Entities / Company
Achieve Life Sciences (United States).
organization
- Reports this week
- 0
- Active events
- 0
- Connections
- 28
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Gone quiet
No new reports in 90+ days-
Achieve Life Sciences is seeking FDA approval for its cytisinicline drug, and HC Wainwright has initiated coverage with a Buy rating.Well supported6 reports1 development inside
-
Achieve Life Sciences (ACHV) could benefit from Trump-era tariffs, and Rogue Funds highlighted the company in its investor letter.Speculative1 report
-
Omnicom Group was appointed as the agency of record for Achieve Life Sciences' US launch starting July 6, 2025.Speculative1 report1 development inside
-
Omnicom Group assembled a team, including Goodby, Silverstein & Partners, to handle the U.S. commercial launch planning for Achieve Life Sciences.Speculative1 report
-
Achieve Life Sciences seeks FDA marketing approval for cytisinicline and filed a registration statement with the SEC, with Raymond James as joint book-running manager.Speculative3 reports
-
Achieve Life Sciences submitted a New Drug Application to the FDA regarding the smoking health epidemic in the US.Some support2 reports
-
Achieve Life Sciences announced its participation from Vancouver.Some support3 reports
No events began in the chosen period. Widen it, or reset.
Around Achieve Life Sciences (United States) this week
News at the entities that move Achieve Life Sciences (United States) most-
FDA StructuralIndian products were subject to an FDA recall.Moves Achieve Life Sciences (United States)
-
Food and Drug Administration StructuralFDA ordered the recall of a batch of cow ghee from Patanjali Foods Limited in Madhya Pradesh.Moves Achieve Life Sciences (United States)
-
Securities and Exchange Commission StructuralConnect Biopharma Holdings Limited filed disclosures with the SEC and its stock is traded on the Nasdaq exchange.Moves Achieve Life Sciences (United States)
Connections
The 6 strongest of 28, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
Achieve Life Sciences relies on the FDA for formal regulatory approval of its drug candidates.
-
Rick Stewart Structural
Rick Stewart serves as the Chief Executive Officer of Achieve Life Sciences.
-
Food and Drug Administration Structural
Achieve Life Sciences seeks formal marketing approval from the Food and Drug Administration for its new drug applications.
-
Securities and Exchange Commission Structural
Achieve Life Sciences operates under the regulatory requirements and filing mandates of the Securities and Exchange Commission.
-
Omnicom Group Operational
Omnicom Group acts as a strategic innovation partner and agency of record for Achieve Life Sciences' US commercial launch.
-
Raymond James Transactional
Raymond James served as a joint book-running manager for Achieve Life Sciences.
History
Events by the month they beganJune 2026
7 events- Achieve Life Sciences is seeking FDA approval for its cytisinicline drug, and HC Wainwright has initiated coverage with a Buy rating.
- Achieve Life Sciences (ACHV) could benefit from Trump-era tariffs, and Rogue Funds highlighted the company in its investor letter.
- Omnicom Group was appointed as the agency of record for Achieve Life Sciences' US launch starting July 6, 2025.
- Omnicom Group assembled a team, including Goodby, Silverstein & Partners, to handle the U.S. commercial launch planning for Achieve Life Sciences.
- Achieve Life Sciences seeks FDA marketing approval for cytisinicline and filed a registration statement with the SEC, with Raymond James as joint book-running manager.
- Achieve Life Sciences submitted a New Drug Application to the FDA regarding the smoking health epidemic in the US.
- Achieve Life Sciences announced its participation from Vancouver.